{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:19:01Z","timestamp":1778055541023,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 72274037"],"award-info":[{"award-number":["No. 72274037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10198-024-01672-4","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T06:01:52Z","timestamp":1709791312000},"page":"1471-1484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China"],"prefix":"10.1007","volume":"25","author":[{"given":"Aixue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuxin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zitong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3661-3944","authenticated-orcid":false,"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"issue":"4","key":"1672_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.pop.2016.07.012","volume":"43","author":"EN Mugnaini","year":"2016","unstructured":"Mugnaini, E.N., Ghosh, N.: Lymphoma. Prim. Care 43(4), 661\u2013675 (2016). https:\/\/doi.org\/10.1016\/j.pop.2016.07.012","journal-title":"Prim. Care"},{"issue":"9844","key":"1672_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland, K.R., Armitage, J.O., Hancock, B.W.: Non-Hodgkin lymphoma. Lancet 380(9844), 848\u2013857 (2012). https:\/\/doi.org\/10.1016\/S0140-6736(12)60605-9","journal-title":"Lancet"},{"issue":"5","key":"1672_CR3","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00520-020-05774-6","volume":"29","author":"RH Xu","year":"2021","unstructured":"Xu, R.H., Wong, E.L., Jin, J., Huang, H., Dong, D.: Health-related quality of life measured using EQ-5D in patients with lymphomas. Support. Care Cancer 29(5), 2549\u20132560 (2021). https:\/\/doi.org\/10.1007\/s00520-020-05774-6","journal-title":"Support. Care Cancer"},{"key":"1672_CR4","unstructured":"Center for disease control and prevention. Leading Cancer Cases and Deaths. [cited 2023 April 20].Available from https:\/\/gis.cdc.gov\/Cancer\/USCS\/DataViz.html."},{"issue":"7","key":"1672_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao, W., Chen, H.D., Yu, Y.W., Li, N., Chen, W.Q.: Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin. Med. J. (Engl.) 134(7), 783\u2013791 (2021). https:\/\/doi.org\/10.1097\/CM9.0000000000001474","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"1","key":"1672_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13045-019-0785-7","volume":"12","author":"W Liu","year":"2019","unstructured":"Liu, W., Liu, J., Song, Y., et al.: Burden of lymphoma in China, 2006\u20132016: an analysis of the Global Burden of Disease Study 2016. J. Hematol. Oncol. 12(1), 115 (2019). https:\/\/doi.org\/10.1186\/s13045-019-0785-7","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"1672_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.rcl.2008.03.005","volume":"46","author":"MJ Matasar","year":"2008","unstructured":"Matasar, M.J., Zelenetz, A.D.: Overview of lymphoma diagnosis and management. Radiol. Clin. North Am. 46(2), 175\u2013vii (2008). https:\/\/doi.org\/10.1016\/j.rcl.2008.03.005","journal-title":"Radiol. Clin. North Am."},{"issue":"6","key":"1672_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1080\/10428194.2020.1867726","volume":"62","author":"S Hu","year":"2021","unstructured":"Hu, S., Chen, N., Lu, K., Zhen, C., Sui, X., Fang, X., Li, Y., Luo, Y., Zhou, X., Wang, X.: The prognostic roles of hepatitis B virus antibody in diffuse large B-cell lymphoma patients. Leukemia Lymphoma. 62(6), 1335\u20131343 (2021). https:\/\/doi.org\/10.1080\/10428194.2020.1867726","journal-title":"Leukemia Lymphoma."},{"issue":"4","key":"1672_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.13067","volume":"28","author":"A Immanuel","year":"2019","unstructured":"Immanuel, A., Hunt, J., McCarthy, H., van Teijlingen, E., Sheppard, Z.A.: Quality of life in survivors of adult haematological malignancy. Eur. J. Cancer Care 28(4), e13067 (2019). https:\/\/doi.org\/10.1111\/ecc.13067","journal-title":"Eur. J. Cancer Care"},{"issue":"10","key":"1672_CR10","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s11136-019-02214-9","volume":"28","author":"K Haraldstad","year":"2019","unstructured":"Haraldstad, K., Wahl, A., Anden\u00e6s, R., et al.: A systematic review of quality of life research in medicine and health sciences. Qual. Life Res. 28(10), 2641\u20132650 (2019). https:\/\/doi.org\/10.1007\/s11136-019-02214-9","journal-title":"Qual. Life Res."},{"key":"1672_CR11","volume-title":"Quality of life: the assessment, analysis and reporting of patient-reported outcomes","author":"PM Fayers","year":"2016","unstructured":"Fayers, P.M., Machin, D.: Quality of life: the assessment, analysis and reporting of patient-reported outcomes, 3rd edn. Wiley, Hoboken (2016)","edition":"3"},{"issue":"12","key":"1672_CR12","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s11136-017-1699-x","volume":"26","author":"AK Po\u00f3r","year":"2017","unstructured":"Po\u00f3r, A.K., Rencz, F., Brodszky, V., Gul\u00e1csi, L., Beretzky, Z., Hidv\u00e9gi, B., Holl\u00f3, P., K\u00e1rp\u00e1ti, S., P\u00e9ntek, M.: Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Qual. Life Res. 26(12), 3409\u20133419 (2017). https:\/\/doi.org\/10.1007\/s11136-017-1699-x","journal-title":"Qual. Life Res."},{"issue":"4","key":"1672_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s12282-021-01230-3","volume":"28","author":"A Nahvijou","year":"2021","unstructured":"Nahvijou, A., Safari, H., Ameri, H.: Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population. Breast cancer (Tokyo, Jpn). 28(4), 937\u2013943 (2021). https:\/\/doi.org\/10.1007\/s12282-021-01230-3","journal-title":"Breast cancer (Tokyo, Jpn)."},{"issue":"5","key":"1672_CR14","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1080\/14737167.2021.1842734","volume":"21","author":"H Ameri","year":"2021","unstructured":"Ameri, H., Safari, H., Poder, T.: Exploring the consistency of the SF-6Dv2 in a breast cancer population. Expert Rev. Pharmacoecon. Outcomes Res. 21(5), 1017\u20131024 (2021). https:\/\/doi.org\/10.1080\/14737167.2021.1842734","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"issue":"1","key":"1672_CR15","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1186\/s12889-023-17208-z","volume":"23","author":"HJ Zhou","year":"2023","unstructured":"Zhou, H.J., Zhang, A., Wei, J., Wu, J., Luo, N., Wang, P.: Psychometric performance of EQ-5D-5L and SF-6DV2 in measuring health status of populations in Chinese university staff and students. BMC Public Health 23(1), 2314 (2023). https:\/\/doi.org\/10.1186\/s12889-023-17208-z","journal-title":"BMC Public Health"},{"issue":"4","key":"1672_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-002317","volume":"3","author":"AW Glaser","year":"2013","unstructured":"Glaser, A.W., Fraser, L.K., Corner, J., et al.: Patient-reported outcomes of cancer survivors in England 1\u20135 years after diagnosis: a cross-sectional survey. BMJ Open 3(4), e002317 (2013). https:\/\/doi.org\/10.1136\/bmjopen-2012-002317","journal-title":"BMJ Open"},{"issue":"10","key":"1672_CR17","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1007\/s00520-017-3725-5","volume":"25","author":"M Jefford","year":"2017","unstructured":"Jefford, M., Ward, A.C., Lisy, K., et al.: Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study. Support. Care Cancer 25(10), 3171\u20133179 (2017). https:\/\/doi.org\/10.1007\/s00520-017-3725-5","journal-title":"Support. Care Cancer"},{"issue":"11","key":"1672_CR18","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.3390\/cancers12113325","volume":"12","author":"RH Xu","year":"2020","unstructured":"Xu, R.H., Wong, E.L., Su, Y., Zhang, H., Zhang, W., Dong, D.: Quantifying the effect of financial burden on health-related quality of life among patients with Non-Hodgkin\u2019s lymphomas. Cancers 12(11), 3325 (2020). https:\/\/doi.org\/10.3390\/cancers12113325","journal-title":"Cancers"},{"issue":"1","key":"1672_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s41687-020-0185-3","volume":"4","author":"M Herdman","year":"2020","unstructured":"Herdman, M., Kerr, C., Pavesi, M., et al.: Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed\/refractory mantle cell lymphoma, and comparison to EQ-5D-5L. J Patient Rep Outcomes. 4(1), 22 (2020). https:\/\/doi.org\/10.1186\/s41687-020-0185-3","journal-title":"J Patient Rep Outcomes."},{"issue":"3","key":"1672_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s11136-013-0537-z","volume":"23","author":"Y Feng","year":"2014","unstructured":"Feng, Y., Parkin, D., Devlin, N.J.: Assessing the performance of the EQ-VAS in the NHS PROMs programme. Qual. Life Res. 23(3), 977\u2013989 (2014). https:\/\/doi.org\/10.1007\/s11136-013-0537-z","journal-title":"Qual. Life Res."},{"issue":"11","key":"1672_CR21","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1007\/s11136-020-02551-0","volume":"29","author":"CW Pan","year":"2020","unstructured":"Pan, C.W., Zhang, R.Y., Luo, N., He, J.Y., Liu, R.J., Ying, X.H., Wang, P.: How the EQ-5D utilities are derived matters in Chinese diabetes patients: a comparison based on different EQ-5D scoring functions for China. Qual. Life Res. 29(11), 3087\u20133094 (2020). https:\/\/doi.org\/10.1007\/s11136-020-02551-0","journal-title":"Qual. Life Res."},{"issue":"4","key":"1672_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo, N., Liu, G., Li, M., Guan, H., Jin, X., Rand-Hendriksen, K.: Estimating an EQ-5D-5L value set for China. Value Health. 20(4), 662\u2013669 (2017). https:\/\/doi.org\/10.1016\/j.jval.2016.11.016","journal-title":"Value Health."},{"issue":"5","key":"1672_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14737167.2023.2189590","volume":"23","author":"A Zhang","year":"2023","unstructured":"Zhang, A., Mao, Z., Wang, Z., Wu, J., Luo, N., Wang, P.: Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review. Expert Rev. Pharmacoecon. Outcomes Res. 23(5), 449\u2013468 (2023). https:\/\/doi.org\/10.1080\/14737167.2023.2189590","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"issue":"11","key":"1672_CR24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0895-4356(98)00103-6","volume":"51","author":"J Brazier","year":"1998","unstructured":"Brazier, J., Usherwood, T., Harper, R., Thomas, K.: Deriving a preference-based single index from the UK SF-36 Health Survey. J. Clin. Epidemiol. 51(11), 1115\u20131128 (1998). https:\/\/doi.org\/10.1016\/s0895-4356(98)00103-6","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"1672_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40273-020-00997-1","volume":"39","author":"J Wu","year":"2021","unstructured":"Wu, J., Xie, S., He, X., et al.: Valuation of SF-6Dv2 health states in china using time trade-off and discrete-choice experiment with a duration dimension. Pharmacoeconomics 39(5), 521\u2013535 (2021). https:\/\/doi.org\/10.1007\/s40273-020-00997-1","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"1672_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N.K., Ahmedzai, S., Bergman, B., et al.: The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 85(5), 365\u2013376 (1993). https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"1672_CR27","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s11136-021-02961-8","volume":"31","author":"J van Roij","year":"2022","unstructured":"van Roij, J., Kieffer, J.M., van de Poll-Franse, L., Husson, O., Raijmakers, N.J.H., Gelissen, J.: Assessing measurement invariance in the EORTC QLQ-C30. Qual. Life Res. 31(3), 889\u2013901 (2022). https:\/\/doi.org\/10.1007\/s11136-021-02961-8","journal-title":"Qual. Life Res."},{"issue":"1","key":"1672_CR28","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1186\/s12889-022-13211-y","volume":"22","author":"MJ Pilz","year":"2022","unstructured":"Pilz, M.J., Gamper, E.M., Efficace, F., et al.: EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1036 individuals. BMC Public Health 22(1), 1040 (2022). https:\/\/doi.org\/10.1186\/s12889-022-13211-y","journal-title":"BMC Public Health"},{"issue":"11","key":"1672_CR29","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W., Tubiana, M.: Report of the committee on Hodgkin\u2019s disease staging classification. Can. Res. 31(11), 1860\u20131861 (1971)","journal-title":"Can. Res."},{"issue":"Suppl 1","key":"1672_CR30","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl, R.L., Jacene, H., Kasamon, Y., Lodge, M.A.: From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J. Nucl. Med. 50(Suppl 1), 122S\u201350S (2009). https:\/\/doi.org\/10.2967\/jnumed.108.057307","journal-title":"J. Nucl. Med."},{"key":"1672_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-023-01566-x","author":"S Xie","year":"2023","unstructured":"Xie, S., Wu, J., Chen, G.: Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population. Eur. J. Health Econ. (2023). https:\/\/doi.org\/10.1007\/s10198-023-01566-x","journal-title":"Eur. J. Health Econ."},{"issue":"7","key":"1672_CR32","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s11136-011-0024-3","volume":"21","author":"M Hunger","year":"2012","unstructured":"Hunger, M., Sabariego, C., Stollenwerk, B., Cieza, A., Leidl, R.: Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation. Qual. Life Res. 21(7), 1205\u20131216 (2012). https:\/\/doi.org\/10.1007\/s11136-011-0024-3","journal-title":"Qual. Life Res."},{"issue":"8476","key":"1672_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland, J.M., Altman, D.G.: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476), 307\u2013310 (1986)","journal-title":"Lancet"},{"issue":"3","key":"1672_CR34","first-page":"69","volume":"24","author":"MM Mukaka","year":"2012","unstructured":"Mukaka, M.M.: Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med. J. 24(3), 69\u201371 (2012)","journal-title":"Malawi Med. J."},{"issue":"6","key":"1672_CR35","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2019.71","volume":"5","author":"M Heslin","year":"2019","unstructured":"Heslin, M., Chua, K.C., Trevillion, K., Nath, S., Howard, L.M., Byford, S.: Psychometric properties of the five-level EuroQoL-5 dimension and Short Form-6 dimension measures of health-related quality of life in a population of pregnant women with depression. BJPsych Open. 5(6), e88 (2019). https:\/\/doi.org\/10.1192\/bjo.2019.71","journal-title":"BJPsych Open."},{"issue":"2","key":"1672_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/s0895-4356(02)00601-7","volume":"56","author":"RH Osborne","year":"2003","unstructured":"Osborne, R.H., Hawthorne, G., Lew, E.A., Gray, L.C.: Quality of life assessment in the community-dwelling elderly: validation of the Assessment of quality of life (AQoL) instrument and comparison with the SF-36. J. Clin. Epidemiol. 56(2), 138\u2013147 (2003). https:\/\/doi.org\/10.1016\/s0895-4356(02)00601-7","journal-title":"J. Clin. Epidemiol."},{"issue":"10","key":"1672_CR37","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1007\/s11136-021-02893-3","volume":"30","author":"D Long","year":"2021","unstructured":"Long, D., Polinder, S., Bonsel, G.J., Haagsma, J.A.: Test-retest reliability of the EQ-5D-5L and the reworded QOLIBRI-OS in the general population of Italy, the Netherlands, and the United Kingdom. Qual. Life Res. 30(10), 2961\u20132971 (2021). https:\/\/doi.org\/10.1007\/s11136-021-02893-3","journal-title":"Qual. Life Res."},{"issue":"3","key":"1672_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh, M.L.: Interrater reliability: the kappa statistic. Biochem. Med. 22(3), 276\u2013282 (2012)","journal-title":"Biochem. Med."},{"issue":"12","key":"1672_CR39","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1007\/s11136-020-02595-2","volume":"29","author":"K Kangwanrattanakul","year":"2020","unstructured":"Kangwanrattanakul, K., Parmontree, P.: Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population. Qual. Life Res. 29(12), 3407\u20133417 (2020). https:\/\/doi.org\/10.1007\/s11136-020-02595-2","journal-title":"Qual. Life Res."},{"key":"1672_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1477-7525-11-110","volume":"11","author":"M Obradovic","year":"2013","unstructured":"Obradovic, M., Lal, A., Liedgens, H.: Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health Qual. Life Outcomes 11, 110 (2013). https:\/\/doi.org\/10.1186\/1477-7525-11-110","journal-title":"Health Qual. Life Outcomes"},{"issue":"1","key":"1672_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12282-020-01141-9","volume":"28","author":"A Nahvijou","year":"2021","unstructured":"Nahvijou, A., Safari, H., Yousefi, M., Rajabi, M., Arab-Zozani, M., Ameri, H.: Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer (Tokyo, Jpn). 28(1), 130\u2013136 (2021). https:\/\/doi.org\/10.1007\/s12282-020-01141-9","journal-title":"Breast Cancer (Tokyo, Jpn)."},{"key":"1672_CR42","doi-asserted-by":"publisher","first-page":"1160882","DOI":"10.3389\/fendo.2023.1160882","volume":"14","author":"Q Yang","year":"2023","unstructured":"Yang, Q., Huang, D., Jiang, L., Tang, Y., Zeng, D.: Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study. Front. Endocrinol. 14, 1160882 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1160882","journal-title":"Front. Endocrinol."},{"key":"1672_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.vhri.2020.06.006","volume":"24","author":"M Yousefi","year":"2021","unstructured":"Yousefi, M., Nahvijou, A., Sari, A.A., Ameri, H.: Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in patients with colorectal and breast cancer from a developing country. Value Health Reg Issues. 24, 57\u201366 (2021). https:\/\/doi.org\/10.1016\/j.vhri.2020.06.006","journal-title":"Value Health Reg Issues."},{"issue":"4","key":"1672_CR44","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10198-021-01273-5","volume":"22","author":"RH Xu","year":"2021","unstructured":"Xu, R.H., Dong, D., Luo, N., et al.: Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia. Eur. J. Health Econ. 22(4), 547\u2013557 (2021). https:\/\/doi.org\/10.1007\/s10198-021-01273-5","journal-title":"Eur. J. Health Econ."},{"issue":"1","key":"1672_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12955-019-1137-6","volume":"17","author":"Z Ye","year":"2019","unstructured":"Ye, Z., Sun, L., Wang, Q.: A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain. Health Qual. Life Outcomes 17(1), 57 (2019). https:\/\/doi.org\/10.1186\/s12955-019-1137-6","journal-title":"Health Qual. Life Outcomes"},{"key":"1672_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12955-014-0156-6","volume":"12","author":"J Wu","year":"2014","unstructured":"Wu, J., Han, Y., Zhao, F.L., Zhou, J., Chen, Z., Sun, H.: Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients. Health Qual. Life Outcomes 12, 156 (2014). https:\/\/doi.org\/10.1186\/s12955-014-0156-6","journal-title":"Health Qual. Life Outcomes"},{"issue":"9","key":"1672_CR47","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10198-014-0664-7","volume":"16","author":"F Yang","year":"2015","unstructured":"Yang, F., Lau, T., Lee, E., Vathsala, A., Chia, K.S., Luo, N.: Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD). Eur. J. Health Econ. 16(9), 1019\u20131026 (2015). https:\/\/doi.org\/10.1007\/s10198-014-0664-7","journal-title":"Eur. J. Health Econ."},{"issue":"2","key":"1672_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12965","volume":"28","author":"S Li","year":"2019","unstructured":"Li, S., Wang, M., Liu, L., Chen, G.: Which approach is better in eliciting health state utilities from breast cancer patients? Evidence from mainland China. Eur. J. Cancer Care 28(2), e12965 (2019). https:\/\/doi.org\/10.1111\/ecc.12965","journal-title":"Eur. J. Cancer Care"},{"issue":"8","key":"1672_CR49","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s40273-021-01033-6","volume":"39","author":"E McDool","year":"2021","unstructured":"McDool, E., Mukuria, C., Brazier, J.: A comparison of the SF-6Dv2 and SF-6D UK utility values in a mixed patient and healthy population. Pharmacoeconomics 39(8), 929\u2013940 (2021). https:\/\/doi.org\/10.1007\/s40273-021-01033-6","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1672_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/14737167.2021.1829479","volume":"21","author":"K Kangwanrattanakul","year":"2021","unstructured":"Kangwanrattanakul, K.: A comparison of measurement properties between UK SF-6D and English EQ-5D-5L and Thai EQ-5D-5L value sets in general Thai population. Expert Rev. Pharmacoecon. Outcomes Res. 21(4), 765\u2013774 (2021). https:\/\/doi.org\/10.1080\/14737167.2021.1829479","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"issue":"2","key":"1672_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40273-012-0012-7","volume":"31","author":"M Tinelli","year":"2013","unstructured":"Tinelli, M., Ryan, M., Bond, C., Scott, A.: Valuing benefits to inform a clinical trial in pharmacy: do differences in utility measures at baseline affect the effectiveness of the intervention? Pharmacoeconomics 31(2), 163\u2013171 (2013). https:\/\/doi.org\/10.1007\/s40273-012-0012-7","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1672_CR52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40271-017-0220-5","volume":"10","author":"CKH Wong","year":"2017","unstructured":"Wong, C.K.H., Lang, B.H.H., Yu, H.M.S., Lam, C.L.K.: EQ-5D-5L and SF-6D utility measures in symptomatic benign thyroid nodules: acceptability and psychometric evaluation. Patient 10(4), 447\u2013454 (2017). https:\/\/doi.org\/10.1007\/s40271-017-0220-5","journal-title":"Patient"},{"key":"1672_CR53","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.psychres.2019.02.077","volume":"274","author":"E Abdin","year":"2019","unstructured":"Abdin, E., Chong, S.A., Seow, E., et al.: A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore. Psychiatry Res. 274, 400\u2013408 (2019). https:\/\/doi.org\/10.1016\/j.psychres.2019.02.077","journal-title":"Psychiatry Res."},{"issue":"4","key":"1672_CR54","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s11136-004-3211-7","volume":"14","author":"K Stavem","year":"2005","unstructured":"Stavem, K., Fr\u00f8land, S.S., Hellum, K.B.: Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV\/AIDS. Qual. Life Res. 14(4), 971\u2013980 (2005). https:\/\/doi.org\/10.1007\/s11136-004-3211-7","journal-title":"Qual. Life Res."},{"issue":"3","key":"1672_CR55","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jse.2009.10.021","volume":"19","author":"GP Slobogean","year":"2010","unstructured":"Slobogean, G.P., Noonan, V.K., O\u2019Brien, P.J.: The reliability and validity of the Disabilities of Arm, Shoulder, and Hand, EuroQol-5D, Health Utilities Index, and Short Form-6D outcome instruments in patients with proximal humeral fractures. J. Shoulder Elbow Surg. 19(3), 342\u2013348 (2010). https:\/\/doi.org\/10.1016\/j.jse.2009.10.021","journal-title":"J. Shoulder Elbow Surg."},{"issue":"4","key":"1672_CR56","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jval.2010.09.002","volume":"14","author":"DG Whitehurst","year":"2011","unstructured":"Whitehurst, D.G., Bryan, S.: Another study showing that two preference-based measures of health-related quality of life (EQ-5D and SF-6D) are not interchangeable. But why should we expect them to be? Value Health 14(4), 531\u2013538 (2011). https:\/\/doi.org\/10.1016\/j.jval.2010.09.002","journal-title":"Value Health"},{"issue":"9","key":"1672_CR57","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1136\/annrheumdis-2011-200891","volume":"71","author":"C Gaujoux-Viala","year":"2012","unstructured":"Gaujoux-Viala, C., Rat, A.C., Guillemin, F., et al.: Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort. Ann. Rheum. Dis. 71(9), 1478\u20131483 (2012). https:\/\/doi.org\/10.1136\/annrheumdis-2011-200891","journal-title":"Ann. Rheum. Dis."}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-024-01672-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-024-01672-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-024-01672-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T16:02:37Z","timestamp":1729958557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-024-01672-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1672"],"URL":"https:\/\/doi.org\/10.1007\/s10198-024-01672-4","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"6 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of Zhongshan Hospital, Fudan University. Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the final manuscript and consented to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}